End-of-day quote
Shanghai S.E.
06:00:00 2024-05-16 pm EDT
|
5-day change
|
1st Jan Change
|
17.21
CNY
|
+1.18%
|
|
-2.49%
|
-28.62%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
5,319
|
8,417
|
6,061
|
5,438
|
3,882
|
Enterprise Value (EV)
1 |
5,319
|
8,417
|
6,061
|
5,438
|
3,882
|
P/E ratio
|
28.3
x
|
26.4
x
|
20.1
x
|
43.8
x
|
5.74
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
10,846,992
x
|
-
|
5,346,558
x
|
8,054,306
x
|
-
|
EV / Revenue
|
10,846,992
x
|
-
|
5,346,558
x
|
8,054,306
x
|
-
|
EV / EBITDA
|
26,916,475
x
|
-
|
15,764,592
x
|
29,260,535
x
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
2.7
x
|
-
|
2.58
x
|
2.42
x
|
-
|
Nbr of stocks (in thousands)
|
225,562
|
225,562
|
225,562
|
225,562
|
225,562
|
Reference price
2 |
23.58
|
37.32
|
26.87
|
24.11
|
17.21
|
Announcement Date
|
4/25/21
|
3/30/22
|
4/24/23
|
4/26/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
|
602
|
490.3
|
-
|
1,134
|
675.2
|
-
|
EBITDA
|
-
|
197.6
|
-
|
384.5
|
185.9
|
-
|
EBIT
|
-
|
173.8
|
-
|
346.3
|
138.8
|
-
|
Operating Margin
|
-
|
35.44%
|
-
|
30.55%
|
20.56%
|
-
|
Earnings before Tax (EBT)
|
-
|
182.9
|
-
|
346.4
|
141.3
|
-
|
Net income
1 |
-
|
157.3
|
319.4
|
301.7
|
123.4
|
690
|
Net margin
|
-
|
32.09%
|
-
|
26.62%
|
18.28%
|
-
|
EPS
2 |
1.297
|
0.8345
|
1.414
|
1.340
|
0.5500
|
3.000
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/10/20
|
4/25/21
|
3/30/22
|
4/24/23
|
4/26/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
14.2%
|
-
|
13.4%
|
5.37%
|
-
|
ROA (Net income/ Total Assets)
|
-
|
11.2%
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
1,409
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
8.720
|
-
|
10.40
|
9.960
|
-
|
Cash Flow per Share
|
-
|
0.6800
|
-
|
1.330
|
0.7900
|
-
|
Capex
|
-
|
52.7
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
10.75%
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/10/20
|
4/25/21
|
3/30/22
|
4/24/23
|
4/26/24
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -28.62% | 538M | | +17.80% | 66.73B | | +2.92% | 49.79B | | +19.98% | 42.5B | | +20.88% | 26.45B | | +12.04% | 19.66B | | +1.27% | 17.18B | | -22.98% | 15.82B | | +2.77% | 15.56B | | -9.25% | 15.41B |
Other Specialty Chemicals
|